Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Sci Rep ; 13(1): 4474, 2023 03 18.
Artigo em Inglês | MEDLINE | ID: mdl-36934138

RESUMO

From September 2020 to May 2021 Madrid region (Spain) followed a rather unique non-pharmaceutical intervention (NPI) by establishing a strategy of perimeter lockdowns (PLs) that banned travels to and from areas satisfying certain epidemiological risk criteria. PLs were pursued to avoid harsher restrictions, but some studies have found that the particular implementation by Madrid authorities was rather ineffective. Based on Madrid's case, we devise a general, minimal framework to investigate the PLs effectiveness by using a data-driven metapopulation epidemiological model of a city, and explore under which circumstances the PLs could be a good NPI. The model is informed with real mobility data from Madrid to contextualize its results, but it can be generalized elsewhere. The lowest lockdown activation threshold [Formula: see text] considered (14-day cumulative incidence rate of 20 cases per every [Formula: see text] inhabitants) shows a prevalence reduction [Formula: see text] with respect to the scenario [Formula: see text], more akin to the case of Madrid, and assuming no further mitigation. Only the combination of [Formula: see text] and mobility reduction [Formula: see text] can avoid PLs for more than [Formula: see text] of the system. The combination of low [Formula: see text] and strong local transmissibility reduction is key to minimize the impact, but the latter is harder to achieve given that we assume a situation with highly mitigated transmission, resembling the one observed during the second wave of COVID-19 in Madrid. Thus, we conclude that a generalized lockdown is hard to avoid under any realistic setting if only this strategy is applied.


Assuntos
COVID-19 , Epidemias , Humanos , COVID-19/epidemiologia , COVID-19/prevenção & controle , Controle de Doenças Transmissíveis , Epidemias/prevenção & controle , Espanha/epidemiologia
2.
BMC Infect Dis ; 22(1): 511, 2022 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-35650539

RESUMO

BACKGROUND: The COVID-19 outbreak has become the worst pandemic in at least a century. To fight this disease, a global effort led to the development of several vaccines at an unprecedented rate. There have been, however, several logistic issues with its deployment, from their production and transport, to the hesitancy of the population to be vaccinated. For different reasons, an important amount of individuals is reluctant to get the vaccine, something that hinders our ability to control and-eventually-eradicate the disease. MATERIALS AND METHODS: Our aim is to explore the impact of vaccine hesitancy when highly transmissible SARS-CoV-2 variants of concern spread through a partially vaccinated population. To do so, we use age-stratified data from surveys on vaccination acceptance, together with age-contact matrices to inform an age-structured SIR model set in the US. RESULTS: Our results show that per every one percent decrease in vaccine hesitancy up to 45 deaths per million inhabitants could be averted. A closer inspection of the stratified infection rates also reveals the important role played by the youngest groups. The model captures the general trends of the Delta wave spreading in the US (July-October 2021) with a correlation coefficient of [Formula: see text]. CONCLUSIONS: Our results shed light on the role that hesitancy plays on COVID-19 mortality and highlight the importance of increasing vaccine uptake in the population, specially among the eldest age groups.


Assuntos
COVID-19 , Vacinas , COVID-19/epidemiologia , COVID-19/prevenção & controle , Surtos de Doenças/prevenção & controle , Modelos Epidemiológicos , Humanos , Aceitação pelo Paciente de Cuidados de Saúde , SARS-CoV-2 , Hesitação Vacinal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA